Hiroshi Mohri1, Martin Markowitz. 1. Aaron Diamond AIDS Research Center, Rockefeller University, New York, NY 10016, USA.
Abstract
OBJECTIVE: Multidrug-resistant (MDR) HIV-1 variants are thought to be less fit than wild-type virus. In 2005, we reported a case of transmitted MDR HIV-1 infection associated with dual tropism and rapid clinical progression. Here we report the in vitro characterization of the virus isolates. METHODS: Replication characteristics of bulk and clonal isolates from this case (MDR-1) were examined and compared with these of a panel of transmitted MDR and wild-type (WT) viruses (MDR-2 approximately 4, WT-1, 2). RESULTS: Infectivity and frequency of infectious virion of propagated isolates were high in MDR-1 biological clones (mean titer, 3.5 x 10(5) TCID50/mL; mean frequency of infectious virion, 1/2444) and its bulk isolate (3.2 x 10(6) TCID50/mL; 1/301) as compared with the other biological clones (7.3 x 10(3) TCID50/mL; 1/21,320). Upslope (log10 p24/mL/d) of viral replication in peripheral blood mononuclear cell culture was much higher in MDR-1 clones (1.30 +/- 0.30: mean +/- SD) than those of MDR-2 approximately 4 (0.75 +/- 0.08) or WT-1, WT-2 clones (0.82 +/- 0.03). The bulk isolate and dual-tropic biological clones from MDR-1 depleted CD4+ T cells very rapidly in vitro compared with the other viruses tested. CONCLUSIONS: These findings support the hypothesis that MDR HIV-1 can effectively evolve and compensate not only to retain high-level replication but also to exhibit virulence associated with rapid disease progression.
OBJECTIVE: Multidrug-resistant (MDR) HIV-1 variants are thought to be less fit than wild-type virus. In 2005, we reported a case of transmitted MDR HIV-1 infection associated with dual tropism and rapid clinical progression. Here we report the in vitro characterization of the virus isolates. METHODS: Replication characteristics of bulk and clonal isolates from this case (MDR-1) were examined and compared with these of a panel of transmitted MDR and wild-type (WT) viruses (MDR-2 approximately 4, WT-1, 2). RESULTS: Infectivity and frequency of infectious virion of propagated isolates were high in MDR-1 biological clones (mean titer, 3.5 x 10(5) TCID50/mL; mean frequency of infectious virion, 1/2444) and its bulk isolate (3.2 x 10(6) TCID50/mL; 1/301) as compared with the other biological clones (7.3 x 10(3) TCID50/mL; 1/21,320). Upslope (log10 p24/mL/d) of viral replication in peripheral blood mononuclear cell culture was much higher in MDR-1 clones (1.30 +/- 0.30: mean +/- SD) than those of MDR-2 approximately 4 (0.75 +/- 0.08) or WT-1, WT-2 clones (0.82 +/- 0.03). The bulk isolate and dual-tropic biological clones from MDR-1 depleted CD4+ T cells very rapidly in vitro compared with the other viruses tested. CONCLUSIONS: These findings support the hypothesis that MDR HIV-1 can effectively evolve and compensate not only to retain high-level replication but also to exhibit virulence associated with rapid disease progression.
Authors: Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Victoria Manuelli; Patrick Jean-Pierre; Peter Lopez; Anita Shet; Andrea Low; Hiroshi Mohri; Daniel Boden; Paul Racz; Martin Markowitz Journal: J Virol Date: 2006-10-25 Impact factor: 5.103
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: M E Quiñones-Mateu; S C Ball; A J Marozsan; V S Torre; J L Albright; G Vanham; G van Der Groen; R L Colebunders; E J Arts Journal: J Virol Date: 2000-10 Impact factor: 5.103
Authors: C W Hendrix; C Flexner; R T MacFarland; C Giandomenico; E J Fuchs; E Redpath; G Bridger; G W Henson Journal: Antimicrob Agents Chemother Date: 2000-06 Impact factor: 5.191
Authors: R H Lyles; A Muñoz; T E Yamashita; H Bazmi; R Detels; C R Rinaldo; J B Margolick; J P Phair; J W Mellors Journal: J Infect Dis Date: 2000-03 Impact factor: 5.226
Authors: C J Petropoulos; N T Parkin; K L Limoli; Y S Lie; T Wrin; W Huang; H Tian; D Smith; G A Winslow; D J Capon; J M Whitcomb Journal: Antimicrob Agents Chemother Date: 2000-04 Impact factor: 5.191
Authors: M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema Journal: J Virol Date: 1989-05 Impact factor: 5.103
Authors: Viktoriya S Anokhina; John D McAnany; Jessica H Ciesla; Thomas A Hilimire; Netty Santoso; Hongyu Miao; Benjamin L Miller Journal: Bioorg Med Chem Date: 2019-05-09 Impact factor: 3.641
Authors: Martin Markowitz; Florin Vaida; C Bradley Hare; Daniel Boden; Hiroshi Mohri; Frederick M Hecht; Robert C Kalayjian; Ann Conrad; Donna Mildvan; Judith Aberg; Christine Hogan; J Michael Kilby; Henry H Balfour; Kim Schafer; Douglas Richman; Susan Little Journal: J Infect Dis Date: 2010-05-01 Impact factor: 5.226
Authors: Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; Bindukumar Nair; Donald E Sykes; Anardi Agosto-Mujica; Chiu Bin Hsiao; Stanley A Schwartz Journal: J Clin Immunol Date: 2009-06-20 Impact factor: 8.317
Authors: Thomas A Hilimire; Jeffrey M Chamberlain; Viktoriya Anokhina; Ryan P Bennett; Oliver Swart; Jason R Myers; John M Ashton; Ryan A Stewart; Aaron L Featherston; Kathleen Gates; Eric D Helms; Harold C Smith; Stephen Dewhurst; Benjamin L Miller Journal: ACS Chem Biol Date: 2017-05-05 Impact factor: 5.100
Authors: Yemil Atisha-Fregoso; Guadalupe Lima; Virginia Pascual-Ramos; Miguel Baños-Peláez; Hilda Fragoso-Loyo; Juan Jakez-Ocampo; Irazú Contreras-Yáñez; Luis Llorente Journal: PLoS One Date: 2016-07-21 Impact factor: 3.240